High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding

Lucia Rohrer1, Pascale M Ohnsorg, Marc Lehner

  • 1Institute of Clinical Chemistry, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland. lucia.rohrer@usz.ch

Circulation Research
|April 18, 2009
PubMed

Insights

Endothelial cells transport high-density lipoproteins (HDL) via transcytosis, a process crucial for reverse cholesterol transport. This transport involves scavenger receptor class B type I (SR-BI) or ATP-binding cassette transporter G1 (ABCG1), but not ABCA1.

Area of Science:

  • Cardiovascular Biology
  • Endothelial Cell Biology
  • Lipid Metabolism

Background:

  • Cholesterol efflux from macrophage foam cells is a critical step in reverse cholesterol transport, influencing atherosclerosis development.
  • High-density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) act as cholesterol acceptors, requiring passage across the endothelium to reach intimal cells.
  • Previous research demonstrated apoA-I transcytosis across endothelial cells, modulated by ATP-binding cassette transporter A1 (ABCA1).

Purpose of the Study:

  • To investigate the interaction of mature HDL with endothelial cells (ECs).
  • To elucidate the mechanisms and transporters involved in HDL binding, internalization, and transcytosis across ECs.
  • To determine the specific roles of scavenger receptor class B type I (SR-BI), ABCA1, and ATP-binding cassette transporter G1 (ABCG1) in HDL transport.

Main Methods:

  • Utilized cell surface biotinylation and immunofluorescence microscopy to track HDL association with ECs.
  • Employed endothelial cells cultured on inserts to assess HDL binding, internalization, and translocation in a transwell system.
  • Applied RNA interference (RNAi) to silence SR-BI, ABCA1, and ABCG1 expression and evaluate their impact on HDL transport and inulin permeability.

Main Results:

  • Endothelial cells exhibit specific and saturable binding of HDL, with approximately 30% internalized.
  • HDL is translocated from the apical to the basolateral side of ECs in a temperature-dependent manner, with reduced particle size but intact protein.
  • Silencing SR-BI or ABCG1 significantly reduced HDL binding and transcytosis, while ABCA1 silencing had no effect; combined silencing did not further impair HDL transport.

Conclusions:

  • Endothelial cells actively bind, internalize, and transcytose HDL particles.
  • HDL transcytosis across ECs is mediated by either SR-BI or ABCG1, highlighting their distinct roles in reverse cholesterol transport.
  • ABCA1 does not appear to play a significant role in the transcytosis of intact HDL particles by endothelial cells.

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...